
S04 E06: Driving access to all medicines
EMJ GOLD: Pharma news, views and analysis
00:00
Generic Medicine Manufacturers - Are They Increasing Access?
First ever framework that actually exists to evaluate a group of generic and biosimilar medicine manufacturers in terms of access. I saw recently, actually, that Eli Lilly has slashed its prices for insulin about, was it 70%? So I think how the US? Yeah, exactly. It's great to see that finally, greater access is becoming attainable for some patients. And hopefully that can spread the world over. Absolutely.
Play episode from 08:04
Transcript


